Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective

References

• Kavosi Z, Rahimi H, Khanian S, et al. Factors influencing decision making for healthcare services outsourcing: a review and Delphi study. Med J Islam Repub Iran. 2018;32(1):56.
   PubMedGoogle Scholar
• Blaise NYH, Cedric TF. Descriptive epidemiology of uterine cervix cancer at the medical oncology unit of the Yaoundé general hospital-Cameroon. GSC Biol Pharml Sci. 2019;9(1):083–091.
   Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789.
   Web of Science ®Google Scholar
• Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–672.
   PubMed Web of Science ®Google Scholar
• Mariani G, Kasznia-Brown J, Paez D, et al. Improving women’s health in low-income and middle-income countries. Part I: challenges and priorities. Nuclear med commun. 2017;38(12):1019.
   PubMed Web of Science ®Google Scholar
• Kocaöz S, Özçelik H, Talas MS, et al. The effect of education on the early diagnosis of breast and cervix cancer on the women’s attitudes and behaviors regarding participating in screening programs. J Cancer Educ. 2018;33(4):821–832.
   PubMed Web of Science ®Google Scholar
• Tjalma WAA, Kim E, Vandeweyer K. The impact on women’s health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium. Eur J Obstetrics Gynecol Reprod Biol. 2017;212:171–181.
   PubMed Web of Science ®Google Scholar
• Saei Ghare Naz M, Kariman N, Ebadi A, et al. Educational interventions for cervical cancer screening behavior of women: a systematic review. Asian Pac J Cancer Prev. 2018;19(4):875.
   PubMedGoogle Scholar
• Gaffney DK, Hashibe M, Kepka D, et al. Too many women are dying from cervix cancer: problems and solutions. Gynecol Oncol. 2018;151(3):547–554.
   PubMed Web of Science ®Google Scholar
• Shandiz FH, Pasdar A, Afzaljavan F, et al. Major risk factors for cervical cancer in northeast of Iran: evidence from a case-control study. Basic & Clinical Cancer Res. 2020;12(2):91–97.
   Google Scholar
• Guimarães YM, Godoy LR, Longatto-Filho A, et al. Management of early-stage cervical cancer: a literature review. Cancers (Basel). 2022;14(3):575.
   PubMed Web of Science ®Google Scholar
• Mansori K, Khazaei S, Khosravi Shadmani F, et al. Global inequalities in cervical cancer incidence and mortality. Middle East J Cancer. 2018;9(3):235–242.
   Web of Science ®Google Scholar
• Riahi S, Mokhtari AM, Vali M, et al. Incidence and mortality rate of cervix cancer in Iran from 1990 to 2016: a systematic review and meta-analysis. J Contemp Med Sci. 2019;5(1):1–7.
   Web of Science ®Google Scholar
• Human papillomavirus vaccines: WHO position paper, October. 2014. Wkly Epidemiol Rec. 2014 Oct 24;89(43):465–491.
   PubMedGoogle Scholar
• Joulaei H, Women’s Cancer ZN. Care in Iran. Cancer Control. 2019 January-December;26(1):1073274819848432.
   Web of Science ®Google Scholar
• NHS Cevical Cancer Screening Programme. cancerscreening. Available from: https://www.nhs.uk/conditions/cervical-screening/ [Cited 2021 Feb 4].
   Google Scholar
• Brown R, Breugelmans J, Theodoratou D, et al. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin. 2006;22(4):663–670.
   PubMed Web of Science ®Google Scholar
• Borget I, Abramowitz L, Mathevet P. Economic burden of HPV-related cancers in France. Vaccine. 2011 Jul 18;29(32):5245–5249.
   PubMed Web of Science ®Google Scholar
• Annemans L, Rémy V, Lamure E, et al. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. J Med Econ. 2008;11(1):135–150.
   PubMedGoogle Scholar
• Ngcamphalala C, Östensson E, Ginindza TG. The economic burden of cervical cancer in Eswatini: societal perspective. Plos one. 2021;16(4):e0250113.
   PubMed Web of Science ®Google Scholar
• Sargazi N, Daroudi R, Zendehdel K, et al. Economic burden of gynecological cancers in Iran. Value Health Reg Issues. 2022;28:1–6.
   PubMedGoogle Scholar
• Segel J. Cost-of-illness studies–a primer. Res Triangle Park, RTI Inter RTI-UNC Center of Excellence in Health Promotion Economics. 2006. https://pdfs.semanticscholar.org/3bbf/0a03079715556ad816a25ae9bf232b45f2e6.pdf
   Google Scholar
• Hashemipoor Z. The economic burden of Hemophilia A and B in patients referred to the Shahid Dastgheib Hospital in Shiraz in 2017. Shiraz: Shiraz University of Medical Sciences; 2019.
   Google Scholar
• Rezaee M, Morowvat MH, Poursadeghfard M, et al. Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis. BMC Health Serv Res. 2022 Jan 28;22(1):118.
   PubMed Web of Science ®Google Scholar
• Jafari A, Alamdarloo PM, Dehghani M, et al. Economic burden of colorectal cancer: a case of fars, Iran. Cancer Control. 2021;28:1–6.
   Web of Science ®Google Scholar
• Kristina S, Endarti DWI, Andayani T, et al. Direct and indirect cost of diabetes mellitus in Indonesia: a prevalence based study with human capital approach. Il J Pharm Res. 2020;13(1):2050–2057.
   Google Scholar
• Rezaee M, Keshavarz K, Izadi S, et al. Economic burden of multiple sclerosis: a cross-sectional study in Iran. Health Econ Rev. 2022;12(1):1–10.
   PubMed Web of Science ®Google Scholar
• Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014 Apr;32(4):335–344.
   PubMed Web of Science ®Google Scholar
• Details of workers’ wages in 2020. [cited 2021 Oct 28]. Available from: https://alborz.mcls.gov.ir/fa/news/236599/.
   Google Scholar
• Ghaffari Darab M, Keshavarz K, Sadeghi E, et al. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran. BMC Health Serv Res. 2021 Feb 11;21(1):132.
   PubMed Web of Science ®Google Scholar
• Abdoli GH. Estimation Social Discount rate for Iran. Eco Res Rev. 2009;10(3):135–156.
   Google Scholar
• Zendehdel K. Cancer statistics in IR Iran in 2020. Basic & Clinical Cancer Res. 2020;12(4):159–165.
   Google Scholar
• Exchange Rate. Central Bank of the Islamic Republic of Iran. Cited Jun 18, 2021. https://www.cbi.ir/default_en.aspx.
   Google Scholar
• Zhao F, Wen Y, Li Y, et al. Epidemiologic and health economic evaluation of cervical cancer screening in rural China. Asian Pac J Cancer Prev. 2020;21(5):1317.
   PubMedGoogle Scholar
• Eberth JM, Prarelkar P, Nguyen H, et al. The human and economic burden of cervical cancer in Texas. Texas Public Health J. 2013;65(2):51.
   PubMedGoogle Scholar
• Pourmohammadi K, Shojaei P, Rahimi H, et al. Evaluating the health system financing of the Eastern Mediterranean Region (EMR) countries using grey relation analysis and Shannon entropy. Cost Eff Resour Allocation. 2018;16(1):1–9.
   PubMedGoogle Scholar
• Bahmei J, Rahimi H, Saleh Jafari A, et al. Examination of medical and non-medical direct costs of outpatients and hospitalized cancer patients in Shiraz, Iran. Payesh (Health Monitor). 2015;14(6):629–637.
   Google Scholar
• Farahmand Z, Soleimanjahi H, Garshasbi M, et al. Distribution of the most common types of HPV in Iranian women with and without cervical cancer. Women Health. 2021;61(1):73–82.
   PubMed Web of Science ®Google Scholar
• Shah R, Nwankwo C, Kwon Y, et al. Economic and humanistic burden of cervical cancer in the United States: results from a nationally representative survey. J Women’s Health. 2020;29(6):799–805.
   PubMed Web of Science ®Google Scholar
• Wu Q, Jia M, Chen H, et al. The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: a retrospective case series study. PloS one. 2020;15(5):e0232129.
   PubMed Web of Science ®Google Scholar
• Araya LT, Fenta TG, Sander B, et al. Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Health Qual Life Outcomes. 2020;18(1):1–9.
   PubMed Web of Science ®Google Scholar
• Shah R, Corman S, Shah A, et al. Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population. J Med Econ. 2021 Jan 01;24(1):1221–1230.
   PubMed Web of Science ®Google Scholar
• Katanyoo K, Riewpaiboon A, Chaikledkaew U, et al. The cost of locally advanced cervical cancer in Thailand: an empirical study for economic analysis. Asian Pac J Cancer Prev. 2021;22(10):3171–3179.
   PubMedGoogle Scholar
• García-Garrido AB, Vázquez-Rodríguez JA, Grande-Gonzalez E, et al. Coverage and costs of opportunistic screening for cervical cancer in Cantabria (Spain). Gac Sanit. 2013;28(1):14–19.
   PubMed Web of Science ®Google Scholar
• van Ballegooijen M, Koopmanschap MA, Tjokrowardojo AJS, et al. Care and costs for advanced cervical cancer. Eur J Cancer. 1992;28(10):1703–1708.
   Google Scholar
• Salavatiha Z, Farahmand M, Shoja Z, et al. A meta‐analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer. J Med Virol. 2021;93(8):4647–4658.
   PubMed Web of Science ®Google Scholar
• Miryousefiata F, Sangy S. The role of vaccines in the prevention of HPV cervical cancer in Iran between (2018–2020). Bp Int Res Exact Sci (Birex) J. 2021;3(3):229–235.
   Google Scholar
• Sargazi N, Takian A, Daroudi R, et al. Cost–benefit analysis of human papillomavirus vaccine in Iran. 2021.
   Google Scholar
• Ekwunife OI, Lhachimi SK. Cost-effectiveness of human papilloma virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage. BMC Health Serv Res. 2017;17(1):1–12.
   PubMedGoogle Scholar
• Chesson HW, Ekwueme DU, Saraiya M, et al. The cost-effectiveness of male HPV vaccination in the United States. Vaccine. 2011;29(46):8443–8450.
   PubMed Web of Science ®Google Scholar
• Rahimi H, Ostovar R, Vali L, et al. Investigating inappropriate admissions and hospitalizations in Yasuj educational hospitals based on appropriateness evaluation protocol (AEP): a case study in the internal and surgical wards. Int J Health Plann Manage. 2019;34(2):636–643.
   PubMed Web of Science ®Google Scholar